These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 6347380)

  • 1. Comparative clinical efficacy and safety of netilmicin and tobramycin in children with serious gram-negative infections.
    Weippl G
    Clin Ther; 1983; 5(4):342-7. PubMed ID: 6347380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
    Jansen W; Schwarz A
    Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Netilmicin: chemical development and overview of clinical research.
    Herting RL; Lane AZ; Lorber RR; Wright JJ
    Scand J Infect Dis Suppl; 1980; Suppl 23():20-9. PubMed ID: 7010547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical netilmicin compared with tobramycin in the treatment of external ocular infection.
    Milazzo G; Papa V; Carstocea B; Chercota G; Rodica P; Gafencu O; Santocono M
    Int J Clin Pharmacol Ther; 1999 May; 37(5):243-8. PubMed ID: 10363623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Netilmicin treatment of complicated urinary tract infections.
    Madsen PO; Baumueller A; Frimodt-Møller N; Hoyme U; Lau C; Maigaard S; Nielsen OS; Welling PG
    Scand J Infect Dis Suppl; 1980; Suppl 23():128-31. PubMed ID: 6937956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled clinical trial on etimicin, a new aminoglycoside antibiotic, versus netilmicin in the treatment of bacterial infections.
    Zhao C; Li J; Hou J; Guo M; Zhang Y; Chen Y
    Chin Med J (Engl); 2000 Nov; 113(11):1026-30. PubMed ID: 11776118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective double-blind controlled clinical study of sisomicin versus tobramycin.
    Schieker KR; Hofmann HF
    Pharmatherapeutica; 1981; 2(8):499-503. PubMed ID: 7019928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin.
    Lerner AM; Reyes MP; Cone LA; Blair DC; Jansen W; Wright GE; Lorber RR
    Lancet; 1983 May; 1(8334):1123-6. PubMed ID: 6133153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, randomized comparison of the efficacy and safety of netilmicin-clindamycin and tobramycin-clindamycin in the treatment of serious systemic infections.
    Kahalley S; Chandler J; Hawkins J; Norris G; Waugespack R; Snow RM
    Clin Ther; 1985; 7(4):497-506. PubMed ID: 4016829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and toxicity of netilmicin in the treatment of gram-negative infections.
    Buckwold FJ; Ronald AR; Lank B; Thompson L; Fox L; Harding GK
    Can Med Assoc J; 1979 Jan; 120(2):161-7. PubMed ID: 761144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of prospective, controlled clinical trials of gentamicin, tobramycin, amikacin, and netilmicin.
    Cone LA
    Clin Ther; 1982; 5(2):155-62. PubMed ID: 6760967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of netilmicin and tobramycin therapy in patients with renal impairment.
    Gorse GJ; Bernstein JM; Cronin RE; Etzell PS
    Scand J Infect Dis; 1992; 24(4):503-14. PubMed ID: 1411317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Netilmicin in moderate to severe infections in newborns and infants: a study of efficacy, tolerance and pharmacokinetics.
    Henriksson P; Svenningsen NW; Juhlin I; Haeger K
    Scand J Infect Dis Suppl; 1980; Suppl 23():155-9. PubMed ID: 7010546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Netilmicin in the treatment of severe or complicated urinary tract infections.
    Peddie BA; Bailey RR; Blake E; Summerfield MJ
    N Z Med J; 1980 May; 91(660):378-81. PubMed ID: 6931321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Netilmicin in the treatment of infections in patients with cancer.
    Yap BS; Bodney GP
    Arch Intern Med; 1979 Nov; 139(11):1259-62. PubMed ID: 389189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin.
    Edson RS; Keys TF
    Mayo Clin Proc; 1983 Feb; 58(2):99-102. PubMed ID: 6823164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of gentamicin and netilmicin in the treatment of gram-negative infections.
    LeFrock JL; Carr BB; Blias F; Schell RF; Dematteo C; Tillotson JR
    Drug Intell Clin Pharm; 1985 Apr; 19(4):309-15. PubMed ID: 3891278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tobramycin--clinical pharmacology and chemotherapy].
    Periti P
    J Chemother; 1996 Jan; 8 Suppl 1():3-30. PubMed ID: 8948764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative clinical trial of sisomicin and gentamicin in serious systemic gram-negative infections.
    Lorber R; Danzig M; Malfitan VA
    Clin Ther; 1981; 4(4):263-74. PubMed ID: 7332914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Netilmicin in refractory urinary tract infections. Good therapeutic effect in spite of long dosage intervals].
    Brunner FP; Wenk M; Mauracher E; Thiel G; Follath F
    Schweiz Med Wochenschr; 1982 Jun; 112(26):934-41. PubMed ID: 7112061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.